Norfluoxetine inhibits TREK-2 K2P channels by multiple mechanisms including state-independent effects on the selectivity filter gate. (2021)

First Author: Proks P
Attributed to:  Unlocking the Potential of K2P Potassium Channels with Nanobodies funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1085/jgp.202012812

PubMed Identifier: 34032848

Publication URI: http://europepmc.org/abstract/MED/34032848

Type: Journal Article/Review

Volume: 153

Parent Publication: The Journal of general physiology

Issue: 8

ISSN: 0022-1295